Benzene and non-Hodgkin's lymphoma

Journal of Pathology

Volumn 189, Issue 4, 1999, Pages 448-453

  O'Connor, Simon R ^a   Farmer, Peter B ^b   Lauder, Ian ^b  

^a UNIVERSITY HOSPITALS OF LEICESTER NHS TRUST   (United Kingdom)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Aetiology; Benzene; Non Hodgkin's lymphoma

Indexed keywords

BENZENE;

ACUTE GRANULOCYTIC LEUKEMIA; BIOLOGICAL MONITORING; CARCINOGENESIS; DISEASE ASSOCIATION; DNA ADDUCT; HUMAN; MATHEMATICAL MODEL; NONHODGKIN LYMPHOMA; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; REVIEW;

ANIMALS; BENZENE; BONE MARROW DISEASES; DNA DAMAGE; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL MONITORING; HUMANS; LYMPHOMA, NON-HODGKIN; MICE; OCCUPATIONAL DISEASES; OCCUPATIONAL EXPOSURE; RATS; SOLVENTS; VEHICLE EMISSIONS;

EID: 0032716776     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199912)189:4<448::AID-PATH458>3.0.CO;2-K     Document Type: Review

References (112)

1. Cancer Mortality Statistics - Registrations 1991. Office for National Statistics. London: HMSO, 1996.
2. Wingo PA, Ries LA, Rosenberg HM, Miller DS, Edwards BK. Cancer incidence and mortality, 1973-1995. Cancer 1999; 82: 1197-1207.
3. Devesa S, Fears T. Non-Hodgkin's lymphoma - time trends and international data. Cancer Res 1992; 52 (Suppl): 5432s-5440s.
4. Holford TR, Zheng T, Mayne ST, McKay LA. Time-trends of non-Hodgkin's lymphoma - are they real? What do they mean? Cancer Res 1992; 52 (Suppl): 5443s-5446s.
5. Cartwright RA. Changes in the descriptive epidemiology of non-Hodgkin's lymphoma in Great Britain? Cancer Res 1992; 52 (Suppl): 5441s-5442s.
6. Banks PM. Changes in diagnosis of non-Hodgkin's lymphoma over time. Cancer Res 1992; 52 (Suppl): 5443s-5445s.
7. Pearce N, Bethwaite P. Increasing incidence of non-Hodgkin's lymphoma: occupational and environmental factors. Cancer Res 1992; 52 (Suppl): 5496s-5500s.
8. Knowles DM. Immunodeficiency-associated lymphoproliferative disorders. Mod Pathol 1999; 12: 200-207.
9. Isaacson PG, Spencer J. Malignant lymphoma and autoimmune disease. Histopathology 1993; 22: 509-510.
10. Wotherspoon AC. Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet 1991; 338: 1175-1176.
11. Guidano G, Pastore C, Cloghini A, et al. Human herpes virus-8 (HHV-8) in haematopoietic neoplasia. Leuk Lymphoma 1997; 24: 257-266.
12. Uchiyama T. Human T-cell leukaemia virus type 1 (HTLV-1) and human diseases. Annu Rev Immunol 1997; 15: 15-37.
13. Ambinder RF, Lemas MV, Moore S, Young J, Fabian D, Krone C. Epstein-Barr virus and lymphoma. Cancer Treat Res 1999; 99: 27-45.
14. Adami I, Gridley G, Nyren O, et al. Sunlight and non-Hodgkin's lymphoma; a population-based cohort study in Sweden. Int J Cancer 1999; 80: 641-645.
15. Milham S. Increased mortality in amateur radio operators due to lymphatic and hematopoietic malignancies. Am J Epidemiol 1988; 127: 50-54.
16. Youngson JHAM, Clayden AD, Myers A, Cartwright RA. A case control study of adult haematological malignancies in relation to overhead power lines. Br J Cancer 1991; 63: 977-985.
17. Zahm SH. Mortality study of pesticide applicators and other employees of a lawn care service company. J Occup Environ Med 1997; 39: 1055-1067.
18. Fontana A, Picoco C, Masala G, Prastaro C, Vineis P. Incidence rates of lymphomas and environmental measurements of phenoxy herbicides: ecological analysis and case-control study. Arch Environ Health 1998; 53: 384-387.
19. Brown LM, Blair A, Gibson R, et al. Pesticide exposures and other agricultural risk factors for leukaemia among men in Iowa and Minnesota. Cancer Res 1990; 50: 6585-6591.
20. Ward MH, Mark SD, Cantor KP, Weisenburger DD, Correa-Villasenor A, Zahm SH. Drinking water nitrate and the risk of non-Hodgkin's lymphoma. Epidemiology 1996; 7: 465-471.
21. Waterhouse D, Carmen WJ, Schottenfeld D, Gridley G, McLean S. Cancer incidence in the rural community of Tecumseh, Michigan: a pattern of increased lymphopoietic neoplasms. Cancer 1996; 77: 763-770.
22. Hardell L, Van Bavel B, Lindstrom G, et al. Higher concentrations of specific polychlorinated biphenyl congeners in adipose tissue from non-Hodgkin's lymphoma patients compared with controls without a malignant disease. Int J Oncol 1986; 9: 603-608.
23. Rothman N, Cantor KP, Blair A, et al. A nested case-control study of non-Hodgkin's lymphoma and serum organochlorine residues. Lancet 1997; 350: 240-244.
24. Lynge E, Antilla A, Hemminki K. Organic solvents and cancer. Cancer Causes Control 1997; 8: 406-419.
25. Skov T, Lynge E. Cancer risk and exposure to carcinogens in hairdressers. Skin Pharmacol 1994; 7: 94-100.
26. Blair A, Linos A, Stewart PA, et al. Comments on occupational and environmental factors in the origin of non-Hodgkin's lymphoma. Cancer Res 1992; 52 (Suppl): 5501s-5502s.
27. Ott MG, Teta MJ, Greenberg HL. Lymphatic and haematopoietic tissue cancer in a chemical manufacturing environment. Am J Ind Med 1989; 16: 631-643.
28. Wilcosky T, Checkoway H, Marshall E, Tyroler HA. Cancer mortality and solvent exposures in rubber industry. Am Ind Hyg Assoc J 1984; 45: 809-811.
29. Hodgson JT, Jones RD. Mortality of styrene production, polymerisation and processing workers at a site in northwest England. Scand J Work Environ Health 1985; 11: 347-352.
30. Li FP, Fraumeni JR, Mantel N, Miller RW. Cancer mortality among chemists. J Natl Cancer Inst 1969; 43: 1159-1164.
31. ATSDR. Toxicological Profile for Benzene 1 (TP-92/03). Atlanta, GA: U.S. Department of Health and Human Services, 1993.
32. Etkin DS. Volatile Organic Compounds in Indoor Environments. Arlington MA: Cutter Information Corps, 1996.
33. Wallace L. Major sources of benzene exposure. Environ Health Perspect 1989; 82: 165-169.
34. Farris GM, Everitt JI, Irons R, Popp JA. Carcinogenicity of inhaled benzene in CBA mice. Fundam Appl Toxicol 1993; 20: 503-507.
35. Huff JE, Haseman JK, DeMarini DM. Multiple site carcinogenicity of benzene in Fischer 344 rats and B6 C3F1 mice. Environ Health Perspect 1989; 82: 125.
36. Le Noire C. Sur un cas de purpura attribue a l'intoxication par la benzene. Bull Mem Soc Med Hap Paris 1897; 14: 1251.
37. Aksoy M, Erdem S, Erdogan G, Dincol G. Combination of genetic factors and chronic exposure to benzene in the aetiology of leukaemia. Hum Hered 1976; 26: 149-153.
38. Vianna NJ, Polan A. Lymphomas and occupational benzene exposure. Lancet 1979; 1: 1394-1395.
39. Hayes RB, Yin SN, Dosemeci M, et al. Benzene and the dose-related incidence of hematologic neoplasms in China. J Natl Cancer Inst 1997; 89: 1065-1071.
40. Marsh G, Enterline PE, McCraw D. Mortality patterns among petroleum refinery and chemical plant workers. Am J Ind Med 1985; 8: 9-20.
41. Balarajan R. Malignant lymphomas in road transport workers. J Epidemiol Community Health 1983; 37: 279-280.
42. Nilsson RI, Nordlinder R, Horte LG, Jarvholm B. Leukaemia, lymphoma and multiple myeloma in seamen on tankers. Occup Environ Med 1998; 55: 517-521.
43. Forastiere F, Perucci CA, Di Pietro A, et al. Mortality among urban policemen in Rome. Am J Ind Med 1994; 26: 785-798
44. Lagorio S, Forastiere F, Iavaronc I, et al. Mortality of filling station attendants. Scand J Work Environ Health 1995; 20: 331-338.
45. Hunting KL, Longbottom H, Kalavar SS, Stern F, Schwartz E, Welch LS. Haematopoietic cancer mortality among vehicle mechanics. Occup Environ Med 1995; 52: 673-678.
46. Yves Bois F, Jackson ET, Pekari K, Smith MT. Population toxicokinetics of benzene. Environ Health Perspect 1996; 104 (Suppl 6): 1405-1411.
47. WHO. Benzene. International Program on Chemical Safety, Environmental Health Criteria No. 150. Geneva: WHO, 1993.
48. Smith MT. The mechanism of benzene-induced leukaemia: a hypothesis and speculations on the causes of leukaemia. Environ Health Perspect 1996; 104 (Suppl 6): 1219-1225.
49. Snyder R, Hedli CC. An overview of benzene metabolism. Environ Health Perspect 1996; 104 (Suppl 6): 1165-1170.
50. Smith MT, Yager JW, Steinmetz KM, Eastmond DA. Peroxidase-dependent metabolism of benzene's phenolic metabolites and its potential role in benzene toxicity and carcinogenicity. Environ Health Perspect 1989; 82: 23-29.
51. Pellack-Walker P, Blumer JL. DNA damage in LS178YS cells following exposure to benzene metabolites. Mol Pharmacol 1986; 30: 42-47.
52. Low L, Lambert C, Meeks J, Naro P, Mackerer C. Tissue-specific metabolism of benzene in zymbal gland and other solid tumour target tissues in rats. J Am Coll Toxicol 1995; 14: 40-60.
53. Drozd J, Bockowski EJ. Acute benzene poisoning. J Occup Med 1967; 9: 9-11.
54. Clayton GD, Clayton FE (eds). Patty's Industrial Hygiene and Toxicology. 4th rev. edn. New York: John Wiley, 1994.
55. Fishbeck WA, Townsend JC, Swank MG. Effects of chronic occupational exposure to measured concentrations of benzene. J Occup Med 1978; 20: 539-542.
56. Rothman N, Li G-L, Dosemeci M, et al. Hematotoxicity among Chinese workers heavily exposed to benzene. Am J Ind Med 1996; 29: 236-246.
57. Moran JL, Siegel D, Sun X-M, Ross D. Induction of apoptosis by benzene metabolites in HL60 and CD34+ human bone marrow progenitor cells. Mol Pharmacol 1996; 50: 610-615.
58. Gaido K, Wierda D. In vitro effects of benzene metabolites in mouse bone marrow stromal cells. Toxicol Appl Pharmacol 1984; 76: 45-55.
59. Gaido K, Wierda D. Hydroquinone suppression of bone marrow stromal cell supported hematopoiesis in vitro is associated with prostaglandin E2 production. Toxicologist 1986; 6: 286.
60. Kalf GF, Schlosser MJ, Renz JF, Pirozzi SJ. Prevention of benzene-induced myelotoxicity by nonsteroidal anti-inflammatory drugs. Environ Health Perspect 1989; 83: 57-64.
61. Plappert U, Barthel E, Raddatz K, Seidel HJ. Early effects of benzene exposure in mice. Hematological versus genotoxic effects. Arch Toxicol 1994; 68: 284-290.
62. Frantz CE, Chen H, Eastmond DA. Inhibition of human topoisomerase II by bioactive benzene metabolites. Environ Health Perspect 1996; 104 (Suppl 6): 1319-1323.
63. Hutt AM, Kalf GF. Inhibition of human DNA topoisomerase II by hydroquinone and p-benroquinone, reactive metabolites of benzene. Environ Health Perspect 1996; 104 (Suppl 6): 1265-1269.
64. Whitlock JA, Greer JP, Lukens JN. Epipodophyllotoxin-related leukaemia. Identification of a new subset of secondary leukaemia. Cancer 1991; 68: 600-604.
65. Eastmond DA. Induction of micronucleus and aneuploidy by the quinone-forming agents benzene and o-phenylphenol. Toxicol Lett 1993; 67: 105.
66. Dean BJ. Recent findings on the genetic toxicology of benzene, toluene, xylenes and phenols. Mutat Res 1985; 154: 153.
67. Sasiadek M. Non-random distribution of breakpoints in the karyotypes of workers occupationally exposed to benzene. Environ Health Perspect 1992; 97: 255.
68. Irons RD, Stillman WS. The process of leukemogenesis. Environ Health Perspect 1996; 104 (Suppl 6): 1239-1246.
69. Smith M, Rothman N, Zhang L, Wang Y, Hayes R, Yin S-N. Molecular cytogenetics of humans exposed to benzene. Toxicologist 1996; 30: Abstr 911.
70. Nucifora G, Rowley JD. AMLI and the 8:21 and 3;21 translocations in acute and chronic leukaemia. Blood 1995; 81: 1-14.
71. Ho TY, Witz G. Increased gene expression in human promyeloid leukaemia cells exposed to trans,trans-muconaldehyde, a hematotoxic benzene metabolite. Carcinogenesis 1997; 18: 739-744.
72. MacEachern L, Laskin DL. Increased production of tumour necrosis factor-alpha by bone marrow leukocytes following benzene treatment of mice. Toxicol Appl Pharmacol 1992; 113: 260-266.
73. Hazel BA, Baum C, Kalf GF. Hydroquinone, a bioreactive metabolite of benzene, inhibits apoptosis in myeloblasts. Stem Cells 1996; 14: 730-742.
74. Department of the Environment, U.K. United Kingdom National Environment Action Plan (CM3323). London: HMSO, 1997.
75. Salway AG, Eggleston HS, Goodwin JWL, Murrels TP. UK Emissions of Air Pollutants 1970-1995 (AEAT-1746/Issue 1). Abingdon: AEA Technology Plc, 1997.
76. Finlayson-Pitts BJ, Pitts JN Jr. Atmospheric Chemistry: Fundamentals and Experimental Techniques. New York: John Wiley, 1986.
77. IEH. Benzene in the environment: an evaluation of exposure of the U.K. general population and possible adverse health effects. Institute for Environment and Health unpublished report for the Department of the Environment, Transport and the Regions (U.K.), May 1998.
78. EPQAS. Benzene. London: HMSO, 1994.
79. AEA. Air Pollution in the U.K.: 1995 (AEA/RAMP/20112002/002). Abingdon: AEA Technology Plc, 1997.
80. SCAQMD. In-vehicle Characterisation Study in the South Coast Air Basin (ZSCAQMD/89-012). Los Angeles. CA: South Coast Air Quality Management District, 1989.
81. Brown VM, Crump DR. Volatile organic compounds. In: Berry RW, Brown VM, Coward SKD, et al., eds. Indoor Air Quality in Homes: Part I. The Building Research Establishment Indoor Environment Study. London: Building Research Establishment, 1996.
82. AgiPetroli. Unpublished study presented to a meeting held in Rome, Italy, in February 1993: Evaluation of benzene exposure of employees and customers in filling stations of the Agipetroli sector. Data available from AgiPetroli, Sede Centrale, Via Laurentina 449, 00142 Rome, Italy.
83. Mulder YM, Drijver M, Kreis I. Case control study on the association between a cluster of childhood haematopoietic malignancies and local environmental factors in Aalsmeer, The Netherlands. J Epidemiol Community Health 1994; 48: 161-165.
84. Knox EG. Leukaemia clusters in childhood: geographical analysis in Britain. J Epidemiol Community Health 1994; 48: 369-376.
85. Linos A, Blair A, Gibson RW. et al. Leukaemia and non-Hodgkin's lymphoma and residential proximity to industrial plants. Arch Environ Health 1991; 46: 70-74.
86. Shu XO, Gao YT, Brinton LA, et al. A population-based case-control study of childhood leukemia in Shanghai. Cancer 1988; 62: 635-644.
87. Doll R. Urban and rural factors in the aetiology of cancer. Int J Cancer 1991; 47: 803-810.
88. Barnes N, Cartwright RA, O'Brien C, et al. Variation in lymphoma incidence within Yorkshire health region. Br J Cancer 1987; 55: 81-84.
89. Yang CY, Hsieh YC. The relation between population density and cancer mortality in Taiwan. Jpn J Cancer Res 1998; 89: 355-360.
90. Rosenthal GL, Snyder CA. Inhaled benzene reduces aspects of cell-mediated surveillance in mice. Toxicol Appl Pharmacol 1987; 88: 35-43.
91. Rosenthal GL, Snyder CA. Modulation of the immune response to listeria monocytogenes by benzene inhalation. Toxicol Appl Pharmacol 1987; 80: 502-510.
92. Au WW, Ramanujam VM, Ward JB Jr, Legator MS. Chromosome aberrations in lymphocytes of mice after subacute low level inhalation exposure to benzene. Mutat Res 1991; 260: 219-224.
93. Brown EA, Shelley ML, Fisher JW. A pharmacokinetic study of occupational and environmental benzene exposure with regard to gender. Risk Anal 1998; 18: 205-213.
94. IARC. IARC Monographs on the Evaluation of Carcinogenic Risk to Humans: Diesel and Gasoline Engine Exhausts and Some Nitroarenes. Lyon: IARC, 1989.
95. Emanuel MB. Hay fever, a post industrial revolution epidemic: a history of its growth during the 19th century. Clin Allergy 1988; 18: 295-304.
96. Takafuji S, Suzuki S, Muranaka M, Miyamoto T. Influence of environmental factors on IgE production. IgE, mast cells and the allergic response. Ciba Found Symp 1989; 147: 188-204.
97. Turner KJ. Epidemiology of the allergic response. In: Wiley C, ed. Mast cells and the allergic response. Ciba Found Symp 1989; 147: 205-229.
98. Takenaka H, Zhang K, Diaz-Sanchez D, Tsien A, Saxon A. Enhanced human IgE production results from exposure to the aromatic hydrocarbons from diesel exhaust: direct effects on B-cell IgE production. J Allergy Clin Immunol 1995; 95: 103-115.
99. Diaz-Sanchez D, Tsien A, Casillas A, Dotson AR, Saxon A. Enhanced nasal cytokine production in human beings after in vivo challenge with diesel exhaust particles. J Allergy Clin Immunol 1996; 98: 114-123.
100. Diaz-Sanchez D, Tsien A, Fleming J, Saxon A. Combined diesel exhaust particulate and ragweed allergen challenge markedly enhances human in vivo nasal ragweed-specific IgE and skews cytokine production to a T helper cell 2-type pattern. J Immunol 1997; 158: 2406-2413.
101. Belpoggi F, Soffritti M, Maltoni C. Methyl-tertiary-butyl ether (MBTE) -a gasoline additive - causes testicular and lymphohaematopoietic cancers in rats. Toxicol Ind Health 1995; 11: 119-149.
102. Kivisto H, Pekari K, Peltonen K, et al. Biological monitoring of exposure to benzene in the production of benzene and in a cokery. Sci Total Environ 1997; 199: 49-63.
103. Bechtold WE, Henderson RF. Biomarkers of human exposure to benzene. J Toxicol Environ Health 1993; 40: 377-386.
104. Ong CN, Lee BL. Determination of benzene and its metabolites: application in biological monitoring of environmental and occupational exposure to benzene. J Chromatogr B Biomed Appl 1994; 660: 1-22.
105. Li G, Wang C, Xin W, Yin S. Tissue distribution of DNA adducts and their persistence in blood of mice exposed to benzene. Environ Health Perspect 1996; 104 (Suppl 6): 1337-1338.
106. Levay G, Pathak DN, Bodell WJ. Detection of DNA adducts in the white blood cells of B6C3F1 mice treated with benzene. Carcinogenesis 1996; 17: 151-153.
107. Mazullo M, Bartoli S, Bonora B. Benzene adducts with rat nucleic acids and proteins: dose-response relationships after treatment. Environ Health Perspect 1989; 82: 259-266.
108. Hemminki K. DNA adducts, mutations and cancer. Carcinogenesis 1993; 14: 2007-2012.
109. Farmer PB, Sepai O, Lawrence R, et al. Biomonitoring human exposure to environmental carcinogenic chemicals. Mutagenesis 1996; 11: 363-381.
110. Vodicka P, Vodickova L, Hemminki K. 32-P Postlabelling of DNA adducts of styrene-exposed lamination workers. Carcinogenesis 1993; 14: 2059-2061.
111. Phillips DH. Detection of DNA modifications by the 32p-postlabelling assay. Mutat Res 1997; 378: 1-12.
112. Bodell WJ, Levay G, Pongracz K. Investigation of benzene DNA adducts and their detection in human bone marrow. Environ Health Perspect 1993; 99: 241-244.